NDC 70436-015 – Olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide

Olmesartan Medoxomil 40 mg/1; Amlodipine Besylate 5 mg/1; Hydrochlorothiazide 12.5 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC70436-015

Product details

Brand name
Olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide
Generic name
Olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide
Labeler
Slate Run Pharmaceuticals, LLC
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
ANDA · ANDA210718
Marketed since
May 15, 2025
Listing expires
December 31, 2026
Pharmacologic class
Angiotensin 2 Receptor Blocker; Calcium Channel Blocker; Dihydropyridine Calcium Channel Blocker; Thiazide Diuretic

Active ingredients

Uses, dosage, side effects and warnings for Olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide →

Package NDC codes (2)

Package NDCDescriptionSince
70436-015-0430 TABLET, FILM COATED in 1 BOTTLE (70436-015-04)May 15, 2025
70436-015-0690 TABLET, FILM COATED in 1 BOTTLE (70436-015-06)May 15, 2025

Other Olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide products